GeneHealth - Your precision medicine

Atrioventricular Septal Defect

Disease Details

Family Health Simplified

Buy Membership

Description: Atrioventricular septal defect (AVSD) is a congenital heart condition characterized by holes between the chambers of the heart and defects in the atrioventricular valves, leading to improper blood flow through the heart.
Type: Atrioventricular septal defect (AVSD) is a congenital heart defect. The genetic transmission of AVSD can vary; though it can occur sporadically, it is sometimes associated with genetic syndromes like Down syndrome (Trisomy 21). The exact mode of transmission for isolated cases of AVSD is not well-defined, but it often involves a combination of genetic and environmental factors.
Signs And Symptoms: Atrioventricular septal defect (AVSD) has the following signs and symptoms:

1. Difficulty breathing or rapid breathing
2. Poor weight gain or failure to thrive
3. Fatigue or weakness, especially during feeding in infants
4. Frequent respiratory infections
5. Bluish skin color (cyanosis) due to poor oxygenation
6. Heart murmur, detectable by a healthcare provider
7. Swelling in the legs, abdomen, or around the eyes
8. Excessive sweating, particularly during feeding or exertion

If you suspect AVSD, it is crucial to consult a healthcare provider for proper diagnosis and management.
Prognosis: Prognosis for atrioventricular septal defect (AVSD) can vary based on the type and severity of the defect, as well as the presence of other medical conditions. With timely surgical intervention, many individuals can lead relatively normal lives. However, potential complications such as arrhythmias, heart failure, and valve problems may occur, necessitating ongoing medical follow-up. Early detection and appropriate treatment are crucial for improving outcomes.
Onset: Atrioventricular septal defect (AVSD) is typically present at birth (congenital). It is a heart defect that involves the walls between the heart's chambers and the valves between the heart's upper and lower chambers. Symptoms associated with AVSD can appear shortly after birth, though occasionally they may not become apparent until later in infancy or childhood.
Prevalence: Atrioventricular septal defect (AVSD), also known as atrioventricular canal defect, occurs in approximately 2 per 10,000 live births. It is more common in individuals with Down syndrome, appearing in about 15-20% of those cases.
Epidemiology: Atrioventricular septal defect (AVSD) is a congenital heart defect that is relatively rare but has notable epidemiological characteristics. The incidence of AVSD is approximately 2 to 4 per 10,000 live births. It is frequently associated with genetic conditions, particularly Down syndrome, in which about 40% of individuals may have this defect. Overall, AVSD represents about 4-5% of all congenital heart defects.
Intractability: Atrioventricular septal defect (AVSD) is not generally considered intractable. It is a congenital heart defect that can often be successfully treated with surgical intervention, especially if diagnosed early in life. The surgical repair typically aims to correct the defects in the heart's septum and restore normal function to the atrioventricular valves. However, the complexity of the defect and the presence of any associated health conditions can affect the outcome and long-term prognosis.
Disease Severity: Atrioventricular septal defect (AVSD) is a congenital heart condition that varies in severity depending on the size and complexity of the defect. It can range from partial forms, which may have less severe symptoms and better outcomes, to complete forms, which are more serious and often require surgical intervention to prevent complications like heart failure or pulmonary hypertension. The severity can impact an individual's quality of life and long-term prognosis.
Healthcare Professionals: Disease Ontology ID - DOID:0050651
Pathophysiology: Atrioventricular septal defect (AVSD) pathophysiology involves a defect in the heart where there is a deficiency or absence of the atrioventricular septum, the part of the heart that separates the atria from the ventricles. This defect results in a communication between the left and right sides of the heart, leading to the mixing of oxygenated and deoxygenated blood. The condition typically includes abnormalities of the atrioventricular valves, which can cause regurgitation and contribute to the inefficiency of blood circulation. Consequently, increased blood volume can overwhelm the lungs, leading to pulmonary over-circulation and congestion, which in turn places strain on the heart and can result in heart failure if left untreated.
Carrier Status: Atrioventricular septal defect (AVSD) is a congenital heart defect, meaning it is present at birth. It is not typically associated with a "carrier status" in the way some genetic conditions are. Instead, AVSD results from abnormal development of the heart during fetal growth. There can be genetic predispositions or syndromes, such as Down syndrome, that increase the likelihood of AVSD, but AVSD itself is not something one can be a carrier for and then pass on without having the condition.
Mechanism: Atrioventricular septal defect (AVSD) is a congenital heart defect characterized by the improper formation of the atrioventricular septum, which is the part of the heart that separates the atria (upper chambers) from the ventricles (lower chambers) and includes the atrioventricular valves.

**Mechanism:**
The primary mechanism involves the failure of the endocardial cushions, which are critical for the proper formation of the heart's septal and valvular structures, to fuse and develop normally during embryogenesis. This results in a spectrum of defects that can range from a partial defect, with a hole in the atrial septum and/or abnormal formation of the mitral and tricuspid valves, to a complete defect, where there is a large single atrioventricular valve connecting all four heart chambers.

**Molecular Mechanisms:**
The molecular mechanisms underlying AVSD involve several key signaling pathways and genetic factors:
1. **Gene Mutations and Genetic Syndromes:** Mutations in several genes, such as those encoding transcription factors (e.g., NKX2-5, GATA4), are implicated in the development of AVSD. Additionally, genetic syndromes such as Down syndrome (trisomy 21) are strongly associated with an increased risk of AVSD.
2. **Signaling Pathways:** The proper differentiation and fusion of the endocardial cushions involve pathways such as the TGF-β (Transforming Growth Factor-beta) pathway, Notch signaling, and Wnt signaling.
3. **Cell Adhesion and Migration:** Proteins involved in cell adhesion and migration, such as those in the cadherin and integrin families, play crucial roles in endocardial cushion formation and remodeling.

Defects in these molecular pathways and genetic alterations disrupt the normal development of the heart's septal and valvular structures, leading to AVSD.
Treatment: Treatment for atrioventricular septal defect (AVSD) typically involves surgical intervention, as this congenital heart defect often requires correction to improve heart function and prevent complications. The surgery usually consists of closing the holes in the septum and repairing or replacing the valves if necessary.

Non-surgical management may include medications to manage symptoms and complications, such as diuretics for fluid retention and medications to control heart rate and blood pressure. Regular monitoring by a cardiologist is essential.

If nan refers to specific or additional information, please provide more context for further clarification.
Compassionate Use Treatment: Atrioventricular septal defect (AVSD) is typically addressed through surgical intervention, but when considering compassionate use treatments or off-label/experimental therapies, options might still be limited due to the nature of the condition.

1. **Compassionate Use Treatments:**
- Compassionate use typically involves access to unapproved or investigational therapies for seriously ill patients who have no other treatment options. In the context of AVSD, this could theoretically involve innovative cardiac surgical techniques or devices under investigation.

2. **Off-label or Experimental Treatments:**
- **Medications:** There are not specific off-label medications for treating AVSD itself, but medications might be used to manage symptoms or related conditions, such as diuretics for heart failure or antiarrhythmic drugs if arrhythmias are present.
- **Stem Cell Therapy:** Experimental approaches, like regenerative medicine or stem cell therapy, are being explored for various cardiac conditions, although they are not standard for AVSD.
- **Gene Therapy:** As with stem cell therapy, gene therapy is in the experimental stages for various congenital heart defects but is not currently a standard treatment option for AVSD.

Ultimately, surgical repair remains the definitive treatment for AVSD, typically performed during infancy to improve outcomes.
Lifestyle Recommendations: For individuals with atrioventricular septal defect (AVSD), lifestyle recommendations generally focus on maintaining heart health and preventing complications. These may include:

1. **Regular Medical Follow-up**: Regular check-ups with a cardiologist to monitor heart function and manage any complications.
2. **Balanced Diet**: A heart-healthy diet, low in saturated fats, trans fats, cholesterol, and sodium. Eating plenty of fruits, vegetables, whole grains, and lean proteins.
3. **Physical Activity**: Engaging in appropriate physical activities as advised by a healthcare provider. Intensity may vary based on the severity of the condition and overall heart function.
4. **Avoiding Tobacco and Alcohol**: Abstaining from smoking and limiting alcohol intake to support cardiovascular health.
5. **Medication Adherence**: Taking prescribed medications as directed to manage symptoms or prevent complications.
6. **Infection Prevention**: Practicing good hygiene and possibly taking antibiotics before certain dental or surgical procedures to prevent endocarditis, according to the cardiologist's advice.
7. **Stress Management**: Using stress reduction techniques such as meditation, yoga, or other relaxation methods.

Always consult a healthcare provider to tailor these recommendations to individual circumstances and severity of the defect.
Medication: For atrioventricular septal defect (AVSD), medication is often used to manage symptoms and complications, especially before surgical intervention. Common medications include diuretics to reduce fluid accumulation, ACE inhibitors to lower blood pressure and reduce heart workload, and sometimes digoxin to improve heart function. These medications do not cure AVSD but help manage symptoms such as heart failure and improve overall heart function. Surgical repair is the definitive treatment for correcting the defect.
Repurposable Drugs: For atrioventricular septal defect (AVSD), there are no specific repurposable drugs widely recognized for treating the defect itself, as AVSD is primarily a structural heart defect. Treatment typically focuses on surgical intervention to correct the defect, rather than pharmacological approaches. Medications may be used to manage symptoms or complications, such as heart failure or arrhythmias, associated with AVSD, but they do not address the underlying anatomical issue.
Metabolites: Atrioventricular septal defect (AVSD) is a type of congenital heart disease that involves a defect in the heart's structure where the atria and ventricles meet. Because AVSD primarily affects the structural integrity of the heart and the way blood flows through it, there are no specific metabolites exclusively associated with this condition. Instead, AVSD's impact is more mechanical and anatomical rather than metabolic.
Nutraceuticals: There are no nutraceuticals that have been proven to effectively treat or manage atrioventricular septal defect (AVSD). This condition typically requires medical or surgical intervention for proper management. Nutritional supplements do not replace standard treatment protocols such as clinical monitoring and surgical correction.
Peptides: Atrioventricular septal defect (AVSD) is a congenital heart defect that involves holes between the chambers of the heart and abnormalities of the valves that regulate blood flow in the heart. To address your query, there is no direct connection between AVSD and specific peptides. Additionally, "nan" in this context does not provide sufficient information to address any aspect related to AVSD. If you have more specific questions or additional details, please provide them for a more tailored response.